A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs
PDF | HTML | How to cite
Metrics: PDF 1254 views | HTML 1392 views | ?
Anna Li Santi1, Anna Gorrasi1, Mariaevelina Alfieri1, Nunzia Montuori2 and Pia Ragno1
1Department of Chemistry and Biology, University of Salerno, Salerno, Italy
2Department of Translational Medical Sciences, Federico II University, Naples, Italy
Pia Ragno, email: [email protected]
Keywords: uPAR; urokinase receptor; ceRNA; AML
Received: January 16, 2018 Accepted: May 19, 2018 Published: June 12, 2018
Urokinase receptor (uPAR) expression is up-regulated and represents a negative prognostic marker in most cancers. We previously reported that uPAR and CXCR4 can be regulated by common microRNAs in leukemia cells. Transcripts containing response elements for shared microRNAs in their 3’UTR may regulate their availability.
We investigated uPAR 3’UTR capability to recruit microRNAs, thus regulating the expression of their targets. uPAR 3’UTR transfection in KG1 leukemia cells up-regulates the expression of endogenous uPAR. Transfection of uPAR 3’UTR, inserted downstream a reporter gene, increases uPAR expression and simultaneously down-regulates the reporter gene expression. Transfection of uPAR 3’UTR also increases CXCR4 expression; accordingly, uPAR silencing induces down-regulation of CXCR4 expression, through a mechanism involving Dicer, the endoribonuclease required for microRNA maturation.
Transfection of uPAR 3’UTR also increases the expression of pro-tumoral factors and modulates cell adhesion and migration, consistently with the capability of uPAR3’UTR-recruited microRNAs to target several and different transcripts and, thus, functions.
Finally, we found 3’UTR-containing variants of uPAR transcript in U937 leukemia cells, which show higher levels of uPAR expression as compared to KG1 cells, in which these variants are not detected.
These results suggest that uPAR mRNA may recruit oncosuppressor microRNAs, allowing the expression of their targets.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.